ATE361059T1 - Antivirale zusammensetzungen - Google Patents

Antivirale zusammensetzungen

Info

Publication number
ATE361059T1
ATE361059T1 AT03768857T AT03768857T ATE361059T1 AT E361059 T1 ATE361059 T1 AT E361059T1 AT 03768857 T AT03768857 T AT 03768857T AT 03768857 T AT03768857 T AT 03768857T AT E361059 T1 ATE361059 T1 AT E361059T1
Authority
AT
Austria
Prior art keywords
antiviral compositions
antiviral
compositions
oxathiolan
deoxythymidine
Prior art date
Application number
AT03768857T
Other languages
English (en)
Inventor
Gary Wayne Goodson
Alison Green Floyd
Cecilia Carpenter Navy
Original Assignee
Glaxo Group Ltd
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Smithkline Beecham Corp filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE361059T1 publication Critical patent/ATE361059T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03768857T 2002-11-08 2003-11-07 Antivirale zusammensetzungen ATE361059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42518202P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
ATE361059T1 true ATE361059T1 (de) 2007-05-15

Family

ID=32312939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03768857T ATE361059T1 (de) 2002-11-08 2003-11-07 Antivirale zusammensetzungen

Country Status (9)

Country Link
US (1) US20050287177A1 (de)
EP (1) EP1567133B1 (de)
JP (1) JP2006508134A (de)
AT (1) ATE361059T1 (de)
AU (1) AU2003291457A1 (de)
CA (1) CA2505130C (de)
DE (1) DE60313657T2 (de)
ES (1) ES2286471T3 (de)
WO (1) WO2004043433A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
ATE422885T1 (de) 2003-08-26 2009-03-15 Smithkline Beecham Corp Cycloalkyläbü kondensierte indole
TWI457136B (zh) 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
ATE474560T1 (de) * 2005-12-14 2010-08-15 Cipla Ltd Pharmazeutische kombination aus nucleotid und nucleosid-reverse-transkriptase-hemmern (wie tenofovir und lamivudin) in verschiedenen teilen der dosiereinheit
AR059097A1 (es) 2006-01-20 2008-03-12 Tibotec Pharm Ltd Tratamiento a largo plazo de la infeccion por vih
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
US20100184785A1 (en) * 2007-06-06 2010-07-22 Basf Se Pharmaceutical formulation for the production of chewable tablets and lozenges
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
DE602008005462D1 (de) * 2007-06-22 2011-04-21 Bristol Myers Squibb Co Tablettierte atazanavirhaltige zusammensetzungen
KR101057640B1 (ko) * 2009-05-27 2011-08-18 (주)다산메디켐 발포성 층을 포함하는 다층 정제
AR119319A1 (es) * 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
ATE131730T1 (de) * 1991-05-16 1996-01-15 Glaxo Group Ltd Nukleosidanalogen enthaltende antiviren- zubereitungen
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
US6177435B1 (en) * 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
ATE186544T1 (de) * 1992-08-04 1999-11-15 James M Dunn Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof

Also Published As

Publication number Publication date
US20050287177A1 (en) 2005-12-29
DE60313657T2 (de) 2008-01-03
CA2505130A1 (en) 2004-05-27
JP2006508134A (ja) 2006-03-09
AU2003291457A1 (en) 2004-06-03
AU2003291457A8 (en) 2004-06-03
ES2286471T3 (es) 2007-12-01
CA2505130C (en) 2009-10-06
EP1567133B1 (de) 2007-05-02
WO2004043433A2 (en) 2004-05-27
DE60313657D1 (de) 2007-06-14
WO2004043433A3 (en) 2004-12-29
EP1567133A2 (de) 2005-08-31

Similar Documents

Publication Publication Date Title
TW366346B (en) 1,3-oxathiolane nucleoside analogue
DE60313657D1 (de) Antivirale zusammensetzungen
EA199700203A1 (ru) Синергические комбинации зидовудина, 1592u89 и 3тс или ftc
PL398295A1 (pl) Analogi nukleozydów przeciwwirusowych, zawierająca je kompozycja farmaceutyczna i ich zastosowania
AU2003291726A8 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
RS20120139A3 (en) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
UY26615A1 (es) Inhibidor de la glucogeno fosforilasa.
YU74992A (sh) Postupak za pravljenje (-)4-amino-5-fluoro-1-(2-hidroksimetil-1,3-oksatiolan-5-il)-(1h)-pirimidin-2-ona
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
HRP20041092B1 (hr) Novi farmaceutski pripravci flibanserina
UY24930A1 (es) Composiciones farmaceuticas que contienen (2r, cis)-4-amino-1-(2-hidroximetil-1,3 -oxatiolan-5-il)-(1h)-pirimidin-2-ona (lamivudina)
YU58398A (en) Combinations comprising vx478, zidovudine, ftc and/or 3tc for use the terapy of hiv
EP1797077A4 (de) Benzimidazolderivate, diese enthaltende zusammensetzungen, herstellung davon und anwendungen davon i
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
JP2006508134A5 (de)
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
TW200509794A (en) Novel anthelmintic and insecticidal compositions
AR040242A1 (es) Composiciones farmaceuticas
FR2916443B1 (fr) Nouveaux derives analogues de l'herbimycine a, compositions les contenant et utilisation.
AR026255A1 (es) Combinaciones antivirales.
WO2000018383A3 (en) Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
AR040135A1 (es) Nueva formulacion para la administracion parenteral de crobenetina (biii 890)
RU2005138167A (ru) Противовирусное средство (варианты) и способ лечения на его основе

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties